SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharmaceuticals informs about loss of share certificate

09 Aug 2023 Evaluate

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and disclosure Requirements) Regulations, 2015, Jenburkt Pharmaceuticals has informed regarding loss of share certificate(s) received on 8th August, 2023 from the shareholder, Anil Ramesh Patel (Folio No: A000686) as details enclosed. The company is in the process of issuing Letter of Confirmation, after compliance of required formalities.

The above information is a part of company’s filings submitted to BSE. 

Jenburkt Pharma Share Price

1162.00 9.20 (0.80%)
12-May-2026 10:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1869.05
Dr. Reddys Lab 1275.00
Cipla 1299.05
Zydus Lifesciences 944.45
Lupin 2243.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×